Author: Janine Anthes

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Surgery for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Urology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Pharmaceutical Executive Defends 400 Percent Price Hike FRIDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Pharmaceutical Executive Defends 400 Percent Price Hike […]

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Pathology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Radiology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, Sept. […]

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Pharmaceutical Executive Defends 400 Percent Price Hike FRIDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Physicians Often Don’t Address Their Burnout FRIDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Pharmaceutical Executive Defends 400 Percent Price Hike FRIDAY, […]

In phase 2 study, surgery for abnormal acid GER in IPF patients was safe, well-tolerated

Five clusters of T2DM loci and traits, each with distinct tissue-specific enhancer enrichment, identified

Patients with COPD and comorbidities have reduced odds of receiving beneficial treatments